These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16895877)

  • 1. Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice.
    Duivenvoorden I; Voshol PJ; Rensen PC; van Duyvenvoorde W; Romijn JA; Emeis JJ; Havekes LM; Nieuwenhuizen WF
    Am J Clin Nutr; 2006 Aug; 84(2):312-21. PubMed ID: 16895877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
    Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice.
    Volger OL; van der Boom H; de Wit EC; van Duyvenvoorde W; Hornstra G; Plat J; Havekes LM; Mensink RP; Princen HM
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1046-52. PubMed ID: 11397718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.
    Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.
    Lian J; Wei E; Wang SP; Quiroga AD; Li L; Di Pardo A; van der Veen J; Sipione S; Mitchell GA; Lehner R
    Hepatology; 2012 Dec; 56(6):2154-62. PubMed ID: 22707181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.
    Post SM; Groenendijk M; Solaas K; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):768-74. PubMed ID: 14962946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol is required for the secretion of the very-low-density lipoprotein: in vivo studies.
    Khan BV; Fungwe TV; Wilcox HG; Heimberg M
    Biochim Biophys Acta; 1990 Jun; 1044(3):297-304. PubMed ID: 2364096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.
    Huang Y; Ji ZS; Brecht WJ; Rall SC; Taylor JM; Mahley RW
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2952-9. PubMed ID: 10591675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids.
    Garcia Caraballo SC; Comhair TM; Houten SM; Dejong CH; Lamers WH; Koehler SE
    J Nutr Biochem; 2014 Dec; 25(12):1263-74. PubMed ID: 25287814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose ethinyl estradiol on serum concentrations and hepatic secretion of the very-low-density lipoprotein, triacylglycerol, cholesterol, and apolipoprotein A-I in the rat.
    Weinstein I; Wilcox HG; Heimberg M
    Biochim Biophys Acta; 1986 May; 876(3):450-9. PubMed ID: 3085718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
    Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice.
    Mensenkamp AR; van Luyn MJ; van Goor H; Bloks V; Apostel F; Greeve J; Hofker MH; Jong MC; van Vlijmen BJ; Havekes LM; Kuipers F
    J Hepatol; 2000 Aug; 33(2):189-98. PubMed ID: 10952236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of apolipoprotein B-containing lipoproteins by dietary soluble fiber in guinea pigs.
    Fernandez ML; Vergara-Jimenez M; Conde K; Behr T; Abdel-Fattah G
    Am J Clin Nutr; 1997 Mar; 65(3):814-22. PubMed ID: 9062534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE
    FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
    de Beer F; van Dijk KW; Jong MC; van Vark LC; van der Zee A; Hofker MH; Fallaux FJ; Hoeben RC; Smelt AH; Havekes LM
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1800-6. PubMed ID: 10894820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
    J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Patatin-Like Phospholipase Domain Containing Protein 7 Facilitates VLDL Secretion by Modulating ApoE Stability.
    Wang X; Guo M; Wang Q; Wang Q; Zuo S; Zhang X; Tong H; Chen J; Wang H; Chen X; Guo J; Su X; Liang H; Zhou H; Li JZ
    Hepatology; 2020 Nov; 72(5):1569-1585. PubMed ID: 32103509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.